Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590458 · ClinicalTrials.gov registry record · Early Phase 1
Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer
A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 131
- Enrollment target
NCT02590458: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.
NCT02590458 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02590458, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 131 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to test if a short breast MRI scan (about 10 minutes) can be used for breast cancer screening in high risk people and to learn if it is as effective as a routine breast MRI scan (30-60 minutes).
Interventions
- BEHAVIORAL Questionnaire
- PROCEDURE Short Breast MRI (SBMRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2015-10-26 |
| Est. Completion | 2020-11-24 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02590458
The ClinicalTrials.gov registry entry for NCT02590458 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT02590458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02590458 about?
NCT02590458 is a clinical study titled "Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer". The goal of this clinical research study is to test if a short breast MRI scan (about 10 minutes) can be used for breast cancer screening in high risk people and to learn if it is as effective as a routine breast MRI scan (30-60 minutes).
What is the current status of trial NCT02590458?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 131 participants. The study started on 2015-10-26. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT02590458?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Short Breast MRI (SBMRI) (PROCEDURE).
Who is sponsoring clinical trial NCT02590458?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.